Prelude Therapeutics Inc
NASDAQ:PRLD
Prelude Therapeutics Inc
NASDAQ:PRLD
Price:
4.08
USD
-7.27%
Market Closed
Market Cap:
$256.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Prelude Therapeutics Inc
NASDAQ:PRLD
|
US |
|
E2E Networks Ltd
NSE:E2E
|
IN |
|
Bayerische Motoren Werke AG
XETRA:BMW
|
DE |
|
F
|
FRoSTA AG
F:NLM
|
DE |
|
Trevali Mining Corp
TSX:TV
|
CA |
|
C
|
Circle Property PLC
LSE:CRC
|
JE |
|
A
|
Abby Inc
OTC:ABBY
|
US |
|
Borussia Dortmund GmbH & Co KGaA
XETRA:BVB
|
DE |
|
G
|
Global Sukses Digital Tbk PT
IDX:DOSS
|
ID |
Income Statement
Earnings Waterfall
Prelude Therapeutics Inc
Prelude Therapeutics Inc
Income Statement
Prelude Therapeutics Inc
Prelude Therapeutics Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3
N/A
|
7
+133%
|
11
+50%
|
12
+16%
|
|
| Operating Income | ||||||||||||||||||||
| Operating Expenses |
(59)
|
(60)
|
(87)
|
(100)
|
(114)
|
(122)
|
(124)
|
(123)
|
(124)
|
(122)
|
(125)
|
(128)
|
(132)
|
(138)
|
(142)
|
(146)
|
(147)
|
(65)
|
(117)
|
|
| Selling, General & Administrative |
(11)
|
(13)
|
(19)
|
(24)
|
(27)
|
(29)
|
(32)
|
(31)
|
(31)
|
(30)
|
(30)
|
(29)
|
(29)
|
(29)
|
(29)
|
(30)
|
(29)
|
(11)
|
(22)
|
|
| Research & Development |
(48)
|
(46)
|
(69)
|
(76)
|
(87)
|
(93)
|
(92)
|
(92)
|
(93)
|
(92)
|
(96)
|
(99)
|
(103)
|
(109)
|
(114)
|
(117)
|
(118)
|
(53)
|
(94)
|
|
| Operating Income |
(59)
N/A
|
(60)
-1%
|
(87)
-47%
|
(100)
-15%
|
(114)
-14%
|
(122)
-7%
|
(124)
-1%
|
(123)
+0%
|
(124)
0%
|
(122)
+1%
|
(125)
-2%
|
(128)
-2%
|
(132)
-3%
|
(138)
-4%
|
(142)
-3%
|
(143)
-1%
|
(140)
+2%
|
(54)
+61%
|
(105)
-93%
|
|
| Pre-Tax Income | ||||||||||||||||||||
| Total Other Income |
2
|
2
|
3
|
2
|
2
|
2
|
3
|
4
|
8
|
9
|
9
|
11
|
10
|
12
|
12
|
12
|
13
|
6
|
5
|
|
| Pre-Tax Income |
(57)
N/A
|
(57)
-1%
|
(84)
-47%
|
(98)
-17%
|
(112)
-14%
|
(120)
-7%
|
(120)
0%
|
(120)
+1%
|
(115)
+4%
|
(114)
+2%
|
(117)
-3%
|
(117)
-1%
|
(122)
-4%
|
(126)
-3%
|
(130)
-3%
|
(132)
-1%
|
(127)
+3%
|
(48)
+62%
|
(99)
-105%
|
|
| Net Income | ||||||||||||||||||||
| Income from Continuing Operations |
(57)
|
(57)
|
(84)
|
(98)
|
(112)
|
(120)
|
(120)
|
(120)
|
(115)
|
(114)
|
(117)
|
(117)
|
(122)
|
(126)
|
(130)
|
(132)
|
(127)
|
(48)
|
(99)
|
|
| Net Income (Common) |
(57)
N/A
|
(57)
-1%
|
(84)
-47%
|
(98)
-17%
|
(112)
-14%
|
(120)
-7%
|
(120)
0%
|
(120)
+1%
|
(115)
+4%
|
(114)
+2%
|
(117)
-3%
|
(117)
-1%
|
(122)
-4%
|
(126)
-3%
|
(130)
-3%
|
(132)
-1%
|
(127)
+3%
|
(48)
+62%
|
(99)
-105%
|
|
| EPS (Diluted) |
-4.56
N/A
|
-1.27
+72%
|
-1.82
-43%
|
-2.11
-16%
|
-2.43
-15%
|
-2.54
-5%
|
-2.54
N/A
|
-2.54
N/A
|
-2.44
+4%
|
-2.39
+2%
|
-2.07
+13%
|
-1.73
+16%
|
-2.02
-17%
|
-1.65
+18%
|
-1.71
-4%
|
-1.73
-1%
|
-1.68
+3%
|
-0.64
+62%
|
-1.29
-102%
|
|
Switch to:
Switch to:
See Also
Discover More
